Christopher & Banks Corporation
CBKCQ · OTC
2/1/2020 | 2/2/2019 | 2/3/2018 | 1/28/2017 | |
|---|---|---|---|---|
| Revenue | $349 | $349 | $366 | $382 |
| % Growth | -0% | -4.6% | -4.1% | – |
| Cost of Goods Sold | $240 | $246 | $252 | $253 |
| Gross Profit | $109 | $103 | $114 | $128 |
| % Margin | 31.2% | 29.4% | 31% | 33.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $116 | $120 | $123 | $134 |
| SG&A Expenses | $116 | $120 | $123 | $134 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $9 | $10 | $12 | $12 |
| Operating Expenses | $125 | $131 | $136 | $146 |
| Operating Income | -$16 | -$32 | -$23 | -$19 |
| % Margin | -4.6% | -9.3% | -6.2% | -4.9% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $1 |
| Pre-Tax Income | -$17 | -$32 | -$23 | -$18 |
| Tax Expense | $0 | $0 | -$1 | -$0 |
| Net Income | -$17 | -$33 | -$22 | -$18 |
| % Margin | -4.8% | -9.4% | -6% | -4.7% |
| EPS | -0.44 | -0.88 | -0.59 | -0.48 |
| % Growth | 50% | -49.2% | -22.9% | – |
| EPS Diluted | -0.44 | -0.88 | -0.59 | -0.48 |
| Weighted Avg Shares Out | 38 | 37 | 37 | 37 |
| Weighted Avg Shares Out Dil | 38 | 37 | 37 | 37 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $9 | $10 | $12 | $12 |
| EBITDA | -$7 | -$22 | -$10 | -$5 |
| % Margin | -2.1% | -6.3% | -2.8% | -1.4% |